CBPO News and Press, China Biologic Products Holdings Inc. From 11/04/19

BEIJING , Nov. 4, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release its third quarter 2019 finan...

BEIJING , Oct. 17, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China , today announced that the special committee (the "Special Committee") of the Compa...

BEIJING , Sept. 24, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China , today announced that its board of directors (the "Board") has formed a spec...

Deals and Financings China Biologic Products (CBPO), a blood products company, received a $4.6 billion takeover offer from a group of six investment firms (see story ). The proposal was priced at $120 per share, a 16% premium to the previous close. CBPO operates plasma-gathering facilities ...

China Biologic Products ( CBPO ) received a $120 per share offer to take the company private. The newly elected CEO has a lot of expertise in the M&A market, which we believe is ideal. He will most likely know how to maximize value for shareholders. Also, the company may need to look for p...

BEIJING , Sept. 18, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China , today announced that its board of directors (the "Board") has received a prelimi...

China Biologic Products Holdings, Inc. (CBPO) Q2 2019 Earnings Conference Call August 06, 2019 7:30 AM ET Company Participants Sam Martin - Foote Group Joseph Chow - Chairman & Chief Executive Officer Ming Yin - Senior Vice President Conference Call Participants Yolanda...

The following slide deck was published by China Biologic Products Holdings, Inc. in conjunction with their 2019 Q2 earnings Read more ...

China Biologic Products (NASDAQ: CBPO ): Q2 Non-GAAP EPS of $1.24 beats by $0.21 ; GAAP EPS of $1.06. More news on: China Biologic Products Holdings, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

--2Q19 Total Sales Up 12.7% YoY in USD terms, or 20.4% YoY in RMB terms; Net Income Up 45.5% YoY to $41.6 Million ; Non-GAAP Adjusted Net Income Up 29.1% YoY in RMB terms -- --1H19 Total Sales Up 14.0% YoY in USD terms, or 21.3% YoY in RMB terms; Net Income Up 31.7% YoY to $79....